Infants with congenital nephrotic syndrome have comparable outcomes to infants with other renal diseases.


Journal

Pediatric nephrology (Berlin, Germany)
ISSN: 1432-198X
Titre abrégé: Pediatr Nephrol
Pays: Germany
ID NLM: 8708728

Informations de publication

Date de publication:
04 2019
Historique:
received: 03 09 2018
accepted: 18 10 2018
revised: 12 10 2018
pubmed: 31 10 2018
medline: 28 4 2020
entrez: 31 10 2018
Statut: ppublish

Résumé

Children with congenital nephrotic syndrome (CNS) commonly develop end stage renal failure in infancy and require dialysis, but little is known about the complications and outcomes of dialysis in these children. We conducted a retrospective case note review across members of the European Society for Pediatric Nephrology Dialysis Working Group to evaluate dialysis management, complications of dialysis, and outcomes in children with CNS. Eighty children (50% male) with CNS were identified form 17 centers over a 6-year period. Chronic dialysis was started in 44 (55%) children at a median age of 8 (interquartile range 4-14) months. Of these, 17 (39%) were on dialysis by the age of 6 months, 30 (68%) by 1 year, and 40 (91%) by 2 years. Peritoneal dialysis (PD) was the modality of choice in 93%, but 34% switched to hemodialysis (HD), largely due to catheter malfunction (n = 5) or peritonitis (n = 4). The peritonitis rate was 0.77 per patient-year. Weight and height SDS remained static after 6 months on dialysis. In the overall cohort, at final follow-up, 29 children were transplanted, 18 were still on dialysis (15 PD, 3 HD), 19 were in pre-dialysis chronic kidney disease (CKD), and there were 14 deaths (8 on dialysis). Median time on chronic dialysis until transplantation was 9 (6-18) months, and the median age at transplantation was 22 (14-28) months. Infants with CNS on dialysis have a comparable mortality, peritonitis rate, growth, and time to transplantation as infants with other primary renal diseases reported in international registry data.

Sections du résumé

BACKGROUND
Children with congenital nephrotic syndrome (CNS) commonly develop end stage renal failure in infancy and require dialysis, but little is known about the complications and outcomes of dialysis in these children.
METHODS
We conducted a retrospective case note review across members of the European Society for Pediatric Nephrology Dialysis Working Group to evaluate dialysis management, complications of dialysis, and outcomes in children with CNS.
RESULTS
Eighty children (50% male) with CNS were identified form 17 centers over a 6-year period. Chronic dialysis was started in 44 (55%) children at a median age of 8 (interquartile range 4-14) months. Of these, 17 (39%) were on dialysis by the age of 6 months, 30 (68%) by 1 year, and 40 (91%) by 2 years. Peritoneal dialysis (PD) was the modality of choice in 93%, but 34% switched to hemodialysis (HD), largely due to catheter malfunction (n = 5) or peritonitis (n = 4). The peritonitis rate was 0.77 per patient-year. Weight and height SDS remained static after 6 months on dialysis. In the overall cohort, at final follow-up, 29 children were transplanted, 18 were still on dialysis (15 PD, 3 HD), 19 were in pre-dialysis chronic kidney disease (CKD), and there were 14 deaths (8 on dialysis). Median time on chronic dialysis until transplantation was 9 (6-18) months, and the median age at transplantation was 22 (14-28) months.
CONCLUSIONS
Infants with CNS on dialysis have a comparable mortality, peritonitis rate, growth, and time to transplantation as infants with other primary renal diseases reported in international registry data.

Identifiants

pubmed: 30374605
doi: 10.1007/s00467-018-4122-0
pii: 10.1007/s00467-018-4122-0
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

649-655

Références

Nephrol Dial Transplant. 2019 Aug 1;34(8):1369-1377
pubmed: 30215773
Nephrol Dial Transplant. 2018 Aug 1;33(8):1459-1465
pubmed: 29617835
Eur J Pediatr. 2018 Jan;177(1):117-124
pubmed: 29143935
Am J Kidney Dis. 2017 May;69(5):617-625
pubmed: 27955924
Pediatr Nephrol. 2014 Jun;29(6):989-97
pubmed: 23812352
J Pediatr. 2009 Jul;155(1):111-7
pubmed: 19324367
Pediatr Nephrol. 2002 Aug;17(8):656-63
pubmed: 12185477
Pediatr Nephrol. 2004 Jan;19(1):82-90
pubmed: 14648343
Pediatr Nephrol. 2017 Dec;32(12):2319-2330
pubmed: 28762101
Pediatr Transplant. 1998 Nov;2(4):305-8
pubmed: 10084734
J Pediatr. 2000 Jan;136(1):24-9
pubmed: 10636969
Pediatr Nephrol. 2000 Oct;14(12):1077-82
pubmed: 11045390
Pediatr Nephrol. 1995 Feb;9(1):87-93
pubmed: 7742232
Pediatr Nephrol. 2016 Dec;31(12):2317-2325
pubmed: 27761660
Pediatr Nephrol. 2009 Nov;24(11):2121-8
pubmed: 17968594
Nephrol Dial Transplant. 2019 Mar 1;34(3):458-467
pubmed: 29474669
Nephrol Dial Transplant. 2012 Jan;27(1):388-95
pubmed: 21669887
Pediatr Nephrol. 2003 May;18(5):426-30
pubmed: 12687455
Pediatr Nephrol. 2016 May;31(5):833-41
pubmed: 26692024
Pediatr Nephrol. 2006 Feb;21(2):257-64
pubmed: 16270221
J Clin Invest. 2017 Mar 1;127(3):912-928
pubmed: 28165339
Perit Dial Int. 2016 9-10;36(5):481-508
pubmed: 27282851
Kidney Int Suppl. 1996 Jan;53:S51-6
pubmed: 8770991

Auteurs

Stephanie Dufek (S)

Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, UK.

Elisa Ylinen (E)

University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Agnes Trautmann (A)

Center for Pediatric and Adolescent Medicine, Heidelberg, Germany.

Harika Alpay (H)

School of Medicine, Marmara University, Istanbul, Turkey.

Gema Ariceta (G)

Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona, Barcelona, Spain.

Christoph Aufricht (C)

Medical University of Vienna, Vienna, Austria.

Justine Bacchetta (J)

Hôpital Femme Mère Enfant, Lyon, France.

Sevcan Bakkaloglu (S)

Gazi University Hospital, Ankara, Turkey.

Aysun Bayazit (A)

Cukurova University, Adana, Turkey.

Salim Caliskan (S)

Cerrahpasa Medical Faculty, Istanbul, Turkey.

Maria do Sameiro Faria (M)

Centro Materno Infantil do Norte, Porto, Portugal.

Ismail Dursun (I)

Erciyes University, Kayseri, Turkey.

Mesiha Ekim (M)

Ankara University Hospital, Ankara, Turkey.

Augustina Jankauskiene (A)

Vilnius University, Vilnius, Lithuania.

Günter Klaus (G)

KfH Pediatric Kidney Center, Marburg, Germany.

Fabio Paglialonga (F)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Andrea Pasini (A)

Azienda Ospedaliero-Universitaria Sant'Orsola-Malpighi, Bologna, Italy.

Nikoleta Printza (N)

1st Pediatric Department, Aristotle University, Thessaloniki, Greece.

Valerie Said Conti (VS)

Mater Dei Hospital Malta, Msida, Malta.

Claus Peter Schmitt (CP)

Center for Pediatric and Adolescent Medicine, Heidelberg, Germany.

Constantinos Stefanidis (C)

"A & P Kyriakou", Children's Hospital, Athens, Greece.

Enrico Verrina (E)

IRCCS Giannina Gaslini, Genoa, Italy.

Enrico Vidal (E)

University-Hospital of Padova, Padova, Italy.

Hazel Webb (H)

Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, UK.

Argyroula Zampetoglou (A)

"A & P Kyriakou", Children's Hospital, Athens, Greece.

Alberto Edefonti (A)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Tuula Holtta (T)

University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Rukshana Shroff (R)

Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, UK. Rukshana.Shroff@gosh.nhs.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH